| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2025 | ATEC Alphatec Holdings, Inc. | Lish Scott61 | Chief Operating Officer | Sell | 27,453 | $11.49 | $315,434.97 | -3.1% | +9.0% | +21.0% | |
| Feb 5, 2025 | ABT Abbott Laboratories | Ford Robert B | Chairman And CEO | Sell | 285,388 | $131.17 | $37,435,200.12 | -56.5% | +0.8% | -17.4% | |
| Feb 5, 2025 | ATEC Alphatec Holdings, Inc. | Miles Patrick53 | CEO | Sell | 43,459 | $11.95 | $519,335.05 | -0.7% | +1.8% | +13.0% | |
| Feb 5, 2025 | TLSI Trisalus Life Sciences, Inc. | Young James Emmett | Chief Financial Officer | Buy | 6,000 | $5.65 | $33,900.00 | +25.0% | -3.6% | -12.2% | |
| Feb 5, 2025 | RMD Resmed Inc | Farrell Peter C55 | Director | Sell | 2,000 | $242.11 | $484,220.00 | -2.5% | -0.3% | +10.1% | |
| Feb 4, 2025 | NXL Nexalin Technology, Inc. | Owens David | Chief Medical Officer | Buy | 1,000 | $3.10 | $3,100.00 | +0.6% | -57.2% | -81.7% | |
| Feb 4, 2025 | NXL Nexalin Technology, Inc. | Owens David | Chief Medical Officer | Buy | 1,000 | $2.98 | $2,980.00 | +0.7% | -57.2% | -81.7% | |
| Feb 4, 2025 | OFIX Orthofix Medical Inc. | Gillespie Geoffrey C80 | CAO | Sell | 954 | $17.85 | $17,025.89 | -1.2% | -27.8% | -31.5% | |
| Feb 3, 2025 | NXGL Nexgel, Inc. | Levy Adam R.77 | Chief Executive Officer | Sell | 4,000 | $3.64 | $14,557.60 | -1.0% | -28.5% | -66.3% | |
| Feb 3, 2025 | RMD Resmed Inc | Rider Michael J49 | Global General Counsel | Sell | 64 | $242.42 | $15,514.88 | -0.7% | +0.0% | +4.5% | |
| Feb 3, 2025 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 18,227 | $0.77 | $14,082.18 | +0.1% | -3.9% | -14.0% | |
| Feb 3, 2025 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 36,256 | $11.42 | $414,043.52 | -4.7% | +4.5% | +28.0% | |
| Feb 3, 2025 | AZTA Azenta, Inc. | Hughes Violetta | VP, Chief Accounting Officer | Sell | 317 | $52.97 | $16,791.49 | -3.2% | -49.7% | -29.1% | |
| Feb 3, 2025 | ELUT Elutia Inc. | Highcape Capital, L.P. | Director, 10% Owner | Buy | 420,000 | $2.50 | $1,050,000.00 | +4.6% | -31.2% | -64.5% | |
| Feb 3, 2025 | BSX Boston Scientific Corp | Butcher Arthur C46 | EVP&Grp Pres, Medsurg &Apac | Sell | 17,313 | $101.80 | $1,762,507.23 | -46.6% | +1.1% | -11.1% | |
| Feb 3, 2025 | ELUT Elutia Inc. | Highcape Capital, L.P. | Director, 10% Owner | Buy | 420,000 | $2.50 | $1,050,000.00 | +4.6% | -31.2% | -64.5% | |
| Feb 3, 2025 | SIBN Si-Bone, Inc. | Dunn Jeffrey W70 | Director | Sell | 337 | $16.51 | $5,562.39 | -1.9% | -16.3% | -4.5% | |
| Feb 3, 2025 | MASS 908 Devices Inc. | Turner Michael S.77 | Chief Legal &Admin Officer | Sell | 9,672 | $2.33 | $22,498.90 | -10.1% | +135.8% | +181.2% | |
| Feb 3, 2025 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 16,001 | $2.32 | $37,109.45 | -0.8% | +135.8% | +181.2% | |
| Feb 3, 2025 | MASS 908 Devices Inc. | Griffith Joseph H. IV81 | Chief Financial Officer | Sell | 10,236 | $2.34 | $23,984.72 | -2.9% | +135.8% | +181.2% | |
| Feb 3, 2025 | MASS 908 Devices Inc. | Brown Christopher D.85 | Chief Product Officer | Sell | 7,767 | $2.34 | $18,190.74 | -0.3% | +135.8% | +181.2% | |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | Mensinger Mike48 | Chief Product Officer | Sell | 13 | $17.00 | $221.00 | - | -53.2% | -41.9% | |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | Mensinger Mike48 | Chief Product Officer | Buy | 33,350 | $17.00 | $566,950.00 | +129.9% | -53.2% | -41.9% | |
| Jan 31, 2025 | SSII Ss Innovations International, Inc. | Srivastava Sudhir | Chairman And CEO | Sell | 182,216 | $1.37 | $250,000.35 | -0.2% | - | - | |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | Wellington Hadley Harbor Aggregator Iv, L.P. | 10% Owner | Buy | 1,000,000 | $17.00 | $17,000,000.00 | +34.5% | -53.2% | -41.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.